Patents Assigned to EmpathBio, Inc.
  • Synthesis of MDMA or its optically active (R)- or (S)-MDMA isomers
    Patent number: 11993577
    Abstract: Provided herein is a process for the preparation of 3,4-methylenedioxymethamphetamine, (R)-3,4-methylenedioxymethamphetamine and (S)-3,4-methylenedioxymethamphetamine.
    Type: Grant
    Filed: September 1, 2022
    Date of Patent: May 28, 2024
    Assignee: EmpathBio, Inc.
    Inventors: Majed Fawaz, Nicholas Morra
  • Nitric oxide releasing prodrugs of MDA and MDMA
    Patent number: 11912680
    Abstract: Provided herein are compounds of Formula (I), Formula (II), and Formula (III) or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7 and A are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), Formula (II), or Formula (III) and methods of using a compound of Formula (I), Formula (II), or Formula (III), e.g., in the treatment of a mental health disease or disorder.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: February 27, 2024
    Assignee: EmpathBio, Inc.
    Inventors: Robert B. Perni, Glenn Short, Tanweer A. Khan
  • Prodrugs of MDMA, MDA, and derivatives thereof
    Patent number: 11845736
    Abstract: The present disclosure provides prodrug compounds of MDMA, MDA, and derivatives thereof having an improved pharmacokinetic profile suitable for the treatment of various neurological diseases.
    Type: Grant
    Filed: October 3, 2022
    Date of Patent: December 19, 2023
    Assignee: EmpathBio, Inc.
    Inventors: Srinivas Rao, Glenn Short, Robert B. Perni, Tanweer A. Khan, Alan C. Gibbs